As of Apr 28
| -2.04 / -6.41%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 28.50, with a high estimate of 38.00 and a low estimate of 18.00. The median estimate represents a -4.27% decrease from the last price of 29.77.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.